The early use of Pasteur's rabies vaccine in the United States

Leonard J. Hoenig; Alan C. Jackson; Gordon Dickinson

doi:10.1016/j.vaccine.2018.05.016

The early use of Pasteur's rabies vaccine in the United States

Leonard J. Hoenig, Alan C. Jackson, Gordon Dickinson

Medicine

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

Louis Pasteur's vaccine against rabies was introduced in France during 1885. A year later it became available within the United States. This article tells the story of the first use of the Pasteur vaccine in America and describes the early history of the vaccine's production and distribution across the country by Pasteur Institutes established for this purpose. Highlights of Pasteur's landmark studies on rabies are presented: research which pioneered the field of virology and the use of immunization to prevent infectious diseases.

Original language	English (US)
Pages (from-to)	4578-4581
Number of pages	4
Journal	Vaccine
Volume	36
Issue number	30
DOIs	https://doi.org/10.1016/j.vaccine.2018.05.016
State	Published - Jul 16 2018

Keywords

Pasteur
Rabies
Vaccine

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2018.05.016

Fingerprint Dive into the research topics of 'The early use of Pasteur's rabies vaccine in the United States'. Together they form a unique fingerprint.

Cite this

Hoenig, L. J., Jackson, A. C., & Dickinson, G. (2018). The early use of Pasteur's rabies vaccine in the United States. Vaccine, 36(30), 4578-4581. https://doi.org/10.1016/j.vaccine.2018.05.016

@article{9a65aa9379c542aab150f78fe1d0782b,

title = "The early use of Pasteur's rabies vaccine in the United States",

abstract = "Louis Pasteur's vaccine against rabies was introduced in France during 1885. A year later it became available within the United States. This article tells the story of the first use of the Pasteur vaccine in America and describes the early history of the vaccine's production and distribution across the country by Pasteur Institutes established for this purpose. Highlights of Pasteur's landmark studies on rabies are presented: research which pioneered the field of virology and the use of immunization to prevent infectious diseases.",

keywords = "Pasteur, Rabies, Vaccine",

author = "Hoenig, {Leonard J.} and Jackson, {Alan C.} and Gordon Dickinson",

year = "2018",

month = jul,

day = "16",

doi = "10.1016/j.vaccine.2018.05.016",

language = "English (US)",

volume = "36",

pages = "4578--4581",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "30",

}

TY - JOUR

T1 - The early use of Pasteur's rabies vaccine in the United States

AU - Hoenig, Leonard J.

AU - Jackson, Alan C.

AU - Dickinson, Gordon

PY - 2018/7/16

Y1 - 2018/7/16

N2 - Louis Pasteur's vaccine against rabies was introduced in France during 1885. A year later it became available within the United States. This article tells the story of the first use of the Pasteur vaccine in America and describes the early history of the vaccine's production and distribution across the country by Pasteur Institutes established for this purpose. Highlights of Pasteur's landmark studies on rabies are presented: research which pioneered the field of virology and the use of immunization to prevent infectious diseases.

AB - Louis Pasteur's vaccine against rabies was introduced in France during 1885. A year later it became available within the United States. This article tells the story of the first use of the Pasteur vaccine in America and describes the early history of the vaccine's production and distribution across the country by Pasteur Institutes established for this purpose. Highlights of Pasteur's landmark studies on rabies are presented: research which pioneered the field of virology and the use of immunization to prevent infectious diseases.

KW - Pasteur

KW - Rabies

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85048592141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048592141&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2018.05.016

DO - 10.1016/j.vaccine.2018.05.016

M3 - Article

C2 - 29921493

AN - SCOPUS:85048592141

VL - 36

SP - 4578

EP - 4581

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 30

ER -